Theodore Ashburn

Officer, Dicerna Pharmaceuticals (United States).

Companies

Oncorus, Inc.Board member Oct 1, 2020 to Mar 2, 2022¹
Oncorus, Inc.Chief executive officer Oct 1, 2020 to Mar 2, 2022¹
Oncorus, Inc.President Oct 1, 2020 to Mar 2, 2022¹
Dicerna Pharmaceuticals (United States)Officer Dec 16, 2014 to Jan 12, 2016²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Oncorus, Inc.99,352 shares³Nov 19, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 19, 2021Exercised options 32,500 shares at $1.81 of Oncorus, Inc.³
Oct 22, 2021Exercised options 43,707 shares at $1.81 of Oncorus, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROncorus, Inc., Board member
2
SEC EDGARDicerna Pharmaceuticals (United States), Officer
3
SEC EDGAROncorus, Inc. shares after the filing of Nov 19, 2021
4
SEC EDGARForm 4 filed Oct 25, 2021